FDA recall D-0429-2019

Lupin Pharmaceuticals Inc. · Class III · drug

Product

Bimatoprost Ophthalmic Solution 0.03%, packaged in a) 5 mL (NDC 68180-429-02) and b) 7.5 mL (NDC 68180-429-03) bottles, Rx only, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA.

Reason for recall

Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities.

Distribution

Nationwide within the United States.

Key facts

Status
Terminated
Initiation date
2019-01-28
Report date
2019-02-13
Termination date
2020-06-22
Voluntary/Mandated
Voluntary: Firm initiated
Location
Baltimore, MD, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0429-2019